NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Prosoma

Prosoma

Private
LondonHealthcare & Life Scienceshttps://www.prosoma.com/

Last Round

Series A

Jan 20, 2025

Total Funding Raised

$9.87M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Prosoma is a health technology company that develops digital therapeutics and behavioral support platforms for cancer patients.

Sector

Healthcare & Life Sciences

Verticals

Mental Health, Medical Devices, Patient Engagement, Telemedicine

Business Model

B2G

Customer Profile

Government Contracts, Subscription SaaS

AI Layer

Application

Keywords

digital therapeuticsDTxpsycho-oncologycancer patient supportDiGADigital Health Applicationsprescription digital therapeuticSoftware as a Medical DeviceSaaMDprescription appCognitive Behavioral TherapyCBTcancer support appbehavioral healthmental health supportpatient engagement

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Prosoma Comps

Public and private peers based on sector, stage, and business model.

Prosoma comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Prosoma Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AJan 20, 2025
SeedDec 22, 2022
GrantDec 1, 2021

Key People

Founding team and executive leadership

Andrzej Jończyk

Co-Founder, Chief Strategy Officer Head Of USA

Founding Team

Jakub Kuziela

CFO COO

Executive Team

Prosoma Investors

Notable investors and investment history

Prosoma investors
InvestorRounds
Convergence Partners AGSeries A
PomerangelsSeed
YouNick MintSeed
Impact VenturesSeries A
EIT HealthGrant
BalnordSeed
Smartlink PartnersSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 15, 2026

    Monthly visitors increased 59% MoM.

  • Sep 9, 2025

    Secured $586K in grant funding.

Prosoma Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Prosoma Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Prosoma's valuation, stock price, and market status.

Firmographic Details

HeadquartersLondon
Employee Range38
Year Founded2018
Last FundingJan 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.